Balyasny Asset Management’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Balyasny Asset Management’s Portfolio DTRT Stock Details DTRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-250,000	Closed	-$2.59M	–	3410
2022 Q4	$2.59M	Sell	250,000 -100,000	-29%	-$1.02M	0.01%	1296
2022 Q3	$3.56M	Hold	350,000	–	–	0.01%	1192
2022 Q2	$3.52M	Hold	350,000	–	–	0.01%	1097
2022 Q1	$3.51M	Hold	350,000	–	–	0.01%	1098
2021 Q4	$3.51M	Buy	+350,000	New	+$3.49M	0.01%	971

Balyasny Asset Management's DTRT Position: Q1 2023 in Review

Balyasny Asset Management sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q1 2023, closing a stake of 250,000 shares — an estimated $2.59M sold.

Balyasny Asset Management first reported a position in DTRT in Q4 2021 and held it in 5 quarters. The position peaked at $3.56M in Q3 2022. 0 funds tracked by Wall St. Rank hold DTRT as of Q1 2023.

Balyasny Asset Management reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Balyasny Asset Management sold 250,000 DTRT Health Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $2.59M.
Balyasny Asset Management first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Balyasny Asset Management's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $3.56M in Q3 2022.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.